Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study
Mario Habek, Gregor Jakob Brecl, Vanja Bašić Kes, Dunja Rogić, Barbara Barun, Tereza Gabelić, Andreja Emeršič, Alenka Horvat Ledinek, Nevena Grbić, Ivana Lapić, Dragana Šegulja, Koraljka Đurić, Ivan Adamec, Magdalena Krbot Skorić
Topics & Concepts
MedicineNatalizumabOcrelizumabAntibodyMultiple sclerosisAlemtuzumabFingolimodTiterImmunologyAntibody titerInternal medicineCladribineRituximabMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and Disorders